Results 91 to 100 of about 10,153 (225)

Cyclic VLCKD Meal Replacement in a Patient with Obesity and Mild Chronic Kidney Disease following Kidney Transplantation

open access: yesObesities, 2022
(1) Background: this work reports the clinical case of a man who underwent a kidney transplant at the age of 19 for idiopathic interstitial nephritis resulting in renal failure.
Luisella Vigna   +5 more
doaj   +1 more source

Effect of oxidative stress on ABC transporters: contribution to epilepsy pharmacoresistance [PDF]

open access: yes, 2017
Epilepsy is a neurological disorder affecting around 1%-2% of population worldwide and its treatment includes use of antiepileptic drugs to control seizures. Failure to respond to antiepileptic drug therapy is a major clinical problem and over expression
Grewal, G. K.   +5 more
core   +2 more sources

Are the Modern Diets for the Treatment of Obesity Better than the Classical Ones?

open access: yesEndocrines, 2022
Conventional hypocaloric diets, providing continuous energy restriction, are considered to be the cornerstone of dietary management of obesity. Although energy-restricted diets are overall safe, healthy, and modestly effective, their long-term adherence ...
Chrysi C. Koliaki   +1 more
doaj   +1 more source

Body Composition Changes After Very-Low-Calorie Ketogenic Diet in Obesity Evaluated by 3 Standardized Methods [PDF]

open access: yesThe Journal of Clinical Endocrinology & Metabolism, 2017
AbstractContext:Common concerns when using low-calorie diets as a treatment for obesity are the reduction in fat-free mass, mostly muscular mass, that occurs together with the fat mass (FM) loss, and determining the best methodologies to evaluate body composition changes.Objective:This study aimed to evaluate the very-low-calorie ketogenic (VLCK) diet ...
D. Gómez-Arbeláez   +9 more
semanticscholar   +3 more sources

Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies. [PDF]

open access: yes, 2017
The treatment of obesity and cardiovascular diseases is one of the most difficult and important challenges nowadays. Weight loss is frequently offered as a therapy and is aimed at improving some of the components of the metabolic syndrome.
Jornayvaz, F.R., Kosinski, C.
core   +3 more sources

Safety of low-carbohydrate diets

open access: yes, 2005
Low-carbohydrate diets have re-emerged into the public spotlight and are enjoying a high degree of popularity as people search for a solution to the population\u27s ever-expanding waistline.
Anderson JW   +47 more
core   +1 more source

Low-carbohydrate diets affect energy balance and fuel homeostasis differentially in lean and obese rats [PDF]

open access: yes, 2006
In parallel with increased prevalence of overweight people in affluent societies are individuals trying to lose weight, often using low-carbohydrate diets.
Dijk, G. van,   +3 more
core   +4 more sources

Very-Low-Calorie Ketogenic Diet as a Safe and Valuable Tool for Long-Term Glycemic Management in Patients with Obesity and Type 2 Diabetes

open access: yesNutrients, 2021
Obesity-related type 2 diabetes represents one of the most difficult challenges for the healthcare system. This retrospective study aims to determine the efficacy, safety and durability of a very-low-calorie ketogenic diet (VLCKD), compared to a standard
E. Moriconi   +4 more
semanticscholar   +1 more source

Possible Nonneurological Health Benefits of Ketogenic Diet: Review of Scientific Reports over the Past Decade

open access: yesJournal of Obesity, 2022
The ketogenic diet (KD) has been used since the 1920s as a therapy for drug-resistant epilepsy. Due to the beneficial effects of this diet on the nervous system and the proposed multifaceted effects of ketones on health and disease, researchers have ...
Katarzyna Daria Gołąbek   +1 more
doaj   +1 more source

Ketogenic diets attenuate cyclooxygenase and lipoxygenase gene expression in multiple sclerosis [PDF]

open access: yes, 2018
Background: Adapted ketogenic diet (AKD) and caloric restriction (CR) have been suggested as alternative therapeutic strategies for inflammatory, hyperproliferative and neurodegenerative diseases.
Bock, Markus   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy